Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zileuton (Zyflo CR) in Sjögren-Larsson Syndrome
2009-015895-87Phase 3Completed
- Sponsor
- Radboud University Medical Center
- Start
- Oct 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, single-arm trial of zileuton extended release in Sjögren-Larsson syndrome (SLS), sponsored by Radboud University Medical Center. Primary endpoints: Clinical improvement in pruritus and skin manifestations and Biochemical changes in leukotriene B4 metabolites. Started Oct 2009; status: completed.
02
Drugs
zileuton extended release
03
Conditions
Sjögren-Larsson syndrome (SLS)
Beyond the preview
Go deeper on 2009-015895-87.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-015895-87.